CACNA1A p.Pro2144=
c.6432G>A · VCV3256962
Computational evidence
| Protein change | ||
| Missense predictors do not apply to this variant type; conservation carries the signal. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
|---|---|---|
| Constraint at this position | ||
| Conservation | phyloP -20 | GERP -4.1 |
| Overall | ||
| CADD | 0.076 | PHRED · no single calibrated threshold — expert panels disagree |
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Ashkenazi Jewishnot grpmax-eligible | 0.00482% | 20,750 |
| African / African-Americangrpmax | 0.00296% | 33,824 |
| European (non-Finnish) | 0.000373% | 268,217 |
Ashkenazi Jewish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- CACNA1A
- Protein
- p.Pro2144=
- Coding
- c.6432G>A
- MANE Select
- NM_001127222
- Type
- single nucleotide variant
- Location
- chr19:13209406 (GRCh38)
- Gene constraint
- LOEUF 0.331 · pLI 1.00 · ClinGen HI 3/3 (gnomAD)
- Structure
- AlphaFold pLDDT 58.34 · 4 PDB
- Residue 2144
- a UniProt-annotated variant site (in ea2 and sca6); the 'disordered' region
Disease context
episodic ataxia type 2 — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsAlso linked: developmental and epileptic encephalopathy, 42
For Familial paroxysmal ataxia (Orphanet):
- Inheritance
- Autosomal dominant
- Onset
- Childhood
- Prevalence
- 1-9 / 1 000 000 (United States)
Similar variants
- CACNA1A p.Pro2144Leu Conflicting classifications of pathogenicity ★ ⚠ same residue
- CACNA1A p.Pro2144Gln Uncertain significance ★ ⚠ same residue
- CACNA1A c.1082+1G>A Pathogenic ★★ same condition
- CACNA1A c.1198+1G>A Pathogenic/Likely pathogenic ★★ same condition
- CACNA1A c.2105-2A>G Likely pathogenic ★★ same condition
- CACNA1A c.3692+1G>A Pathogenic/Likely pathogenic ★★ same condition
- CACNA1A c.3822+1G>A Pathogenic ★★ same condition
- CACNA1A c.3989+1G>A Pathogenic ★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/cacna1a-p-pro2144 (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown